What is the appropriate dose and duration of Bactrim double‑strength (800 mg sulfamethoxazole/160 mg trimethoprim) suspension for treating urinary tract infections in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim DS Dosing for Urinary Tract Infections

For uncomplicated cystitis in adults, prescribe Bactrim DS (trimethoprim-sulfamethoxazole 160/800 mg) one tablet twice daily for 3 days, but only if local resistance rates are below 20% or the organism is known to be susceptible. For pyelonephritis, use one Bactrim DS tablet twice daily for 14 days when the pathogen is confirmed susceptible 1.

Adult Dosing by Infection Type

Uncomplicated Cystitis

  • Dose: 1 Bactrim DS tablet (or 2 regular strength tablets) twice daily
  • Duration: 3 days 1
  • Critical caveat: This is appropriate ONLY if:
    • Local E. coli resistance to TMP-SMX is <20% 1, OR
    • Susceptibility testing confirms the organism is sensitive 1

Important resistance consideration: TMP-SMX is no longer a first-line empiric agent in many regions due to rising resistance rates 1. If you prescribe empirically without knowing local resistance patterns exceeding 20%, you risk treatment failure. Consider nitrofurantoin (5 days) or fosfomycin (single dose) as superior first-line alternatives that minimize collateral damage 1, 2.

Uncomplicated Pyelonephritis

  • Dose: 1 Bactrim DS tablet twice daily
  • Duration: 14 days 1, 3
  • Mandatory requirement: Always obtain urine culture before starting treatment 1
  • Add initial parenteral therapy: If susceptibility is unknown, give one dose of ceftriaxone 1g IV or consolidated aminoglycoside dose before starting oral TMP-SMX 1

Why 14 days? This is the FDA-approved duration with proven efficacy in clinical trials 1. Shorter courses have not been adequately studied for TMP-SMX in pyelonephritis, unlike fluoroquinolones which can be given for 5-7 days 2, 4.

Pediatric Dosing (≥2 months old)

For UTIs and Acute Otitis Media

  • Dose: 40 mg/kg sulfamethoxazole + 8 mg/kg trimethoprim per 24 hours
  • Frequency: Divided into 2 doses every 12 hours
  • Duration: 7-14 days for febrile UTI 5, 3

Weight-based dosing table 3:

  • 10 kg (22 lbs): ½ tablet twice daily
  • 20 kg (44 lbs): 1 tablet twice daily
  • 30 kg (66 lbs): 1½ tablets twice daily
  • 40 kg (88 lbs): 2 tablets (or 1 DS tablet) twice daily

Critical pediatric consideration: Do NOT use nitrofurantoin for febrile UTIs in children, as it doesn't achieve adequate tissue concentrations for pyelonephritis 5. TMP-SMX is acceptable if local susceptibility patterns support its use.

Key Clinical Pitfalls to Avoid

Resistance Patterns Matter

The single biggest mistake is prescribing TMP-SMX empirically without knowing local resistance rates. Studies show that when E. coli resistance exceeds 20%, clinical failure rates increase significantly 1. In patients on chronic TMP-SMX prophylaxis (e.g., for PCP prevention), E. coli susceptibility drops to only 21% 6.

Duration Errors

  • Too short for pyelonephritis: Unlike fluoroquinolones (5-7 days effective), TMP-SMX requires the full 14 days for pyelonephritis 1, 2, 4
  • Too long for cystitis: The 3-day regimen is as effective as 10 days for uncomplicated cystitis, with fewer adverse effects 1, 7

When NOT to Use TMP-SMX

  • Recent antibiotic exposure (especially TMP-SMX or fluoroquinolones) increases resistance risk 1
  • Pregnancy (especially third trimester) 8
  • Children <2 months old 3
  • Empiric therapy when local resistance >20% 1
  • Severe/toxic-appearing pyelonephritis requiring hospitalization (use IV therapy initially) 1

Adverse Effects

TMP-SMX carries higher adverse event rates than alternatives. Meta-analysis shows 3-fold increased risk of rash compared to other antibiotics 9. Serious reactions include Stevens-Johnson syndrome (5-fold increase vs azithromycin), blood dyscrasias (pancytopenia, neutropenia), and electrolyte disturbances (hyperkalaemia, hyponatraemia) 9. Adverse effects occur in 24-31% of patients on standard courses 1, 10.

Renal Dosing Adjustment

For creatinine clearance 15-30 mL/min: Use half the usual dose 3. Below 15 mL/min: Do not use 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.